駱雨利、李新城教授分別以Nanoscale Horizons與 Cancer Letters期刊論文獲選110年本校陽明校區第三季(7-9月)重要論文

110年本校陽明校區第三季(7-9月)重要論文公告: https://rnd.ym.edu.tw/ymrd/rd_system/rd_result_detail.asp?upd125=A
藥理所所教師獲選論文:
駱雨利教授:Gene-editing by CRISPR-Cas9 in combination with anthracycline therapy via tumor microenvironment-switchable, EGFR-targeted, and nucleus-directed nanoparticles for head and neck cancer suppression. Nanoscale Horiz. 2021;6:729-743. (https://pubmed.ncbi.nlm.nih.gov/34323910/)
李新城教授:Mitochondrial stress adaptation promotes resistance to aromatase inhibitor in human breast cancer cells via ROS/calcium up-regulated amphiregulin-estrogen receptor loop signaling. Cancer Lett. 2021;523:82-99. (https://pubmed.ncbi.nlm.nih.gov/34610415/)